Alexander Cheung, based in California, United States, is currently a Senior Director, Research at Lyell Immunopharma, bringing experience from previous roles at Immulus, Inc. - acquired by Lyell Immunopharma May 2020, Wyss Institute for Biologically Inspired Engineering and Unum Therapeutics. Alexander Cheung holds a 2012 - 2016 Doctor of Philosophy - PhD in Engineering Science @ Harvard University. Alexander Cheung has 5 emails and 1 mobile phone number on RocketReach.